Blog
RSS FeedPosted by Michael Wonder on 21 Mar 2019
NICE terminates yet another assessment of a cancer medicine
20 March 2019 - This time it is pembrolizumab (Keytruda). ...
Posted by Michael Wonder on 21 Mar 2019
Is Orkambi deal close? Vertex meets again today with NHS England
21 March 2019 - Campaigners hopes rise after three year wait. ...
Posted by Michael Wonder on 20 Mar 2019
York man Paul Thomas-Peter says he could die because NHS won't fund drug
19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...
Posted by Michael Wonder on 20 Mar 2019
Unprecedented drug shortage linked to Brexit, NHS bosses say
20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...
Posted by Michael Wonder on 20 Mar 2019
The shadow of Brexit on speed of access
20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union. ...
Posted by Michael Wonder on 19 Mar 2019
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
18 March 2019 - Suggests Orkambi row has undermined confidence in NICE process. ...
Posted by Michael Wonder on 18 Mar 2019
CMA drops anti-competitive case against MSD
18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...
Posted by Michael Wonder on 18 Mar 2019
NICE celebrates its 20th anniversary
18 March 2019 - Organisation was founded in April 1999 to improve outcome for health service users ...
Posted by Michael Wonder on 14 Mar 2019
One in four cancer patients wait two months for treatment, as NHS performance hits record low
14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...
Posted by Michael Wonder on 14 Mar 2019
UK breast cancer patients win early access to Tecentriq/nab-paclitaxel
14 March 2019 - Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer have ...
Posted by Michael Wonder on 13 Mar 2019
Cancer patient denied life-prolonging drug as she lives half a mile outside England
13 March 2019 - A seriously ill mum-of-two has spoken of her devastation after being denied a life prolonging cancer drug ...
Posted by Michael Wonder on 13 Mar 2019
Pharma urges politicians to stop no-deal Brexit in today’s vote
13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...
Posted by Michael Wonder on 12 Mar 2019
Optimism on Orkambi in England as talks to resume
12 March 2019 - Scotland's deal puts pressure on NHS England and NICE. ...
Posted by Michael Wonder on 12 Mar 2019
NICE u-turn backs use of Darzalex combo for myeloma relapse
12 March 2019 - Myeloma patients in England are set to gain NHS access to a new second-line treatment combination ...
Posted by Michael Wonder on 11 Mar 2019
NICE nod for Almirall's Ilumetri, UCB's Cimzia
11 March 2019 - The NICE has recommended Almirall's Ilumetri and UCB's Cimzia as a treatment options for severe plaque ...